Alpha Centric Advisors LLC has filed its 13F form on July 25, 2024 for Q2 2024 where it was disclosed a total value porftolio of $121 Million distributed in 218 stocks.

Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $4.62M, Biocryst Pharmaceuticals Inc with a value of $4.17M, Pfizer Inc with a value of $3.92M, Harmony Biosciences Holdings, Inc. with a value of $3.68M, and Pacira Bio Sciences, Inc. with a value of $3.36M.

Examining the 13F form we can see an decrease of $23.2M in the current position value, from $144M to 121M.

Alpha Centric Advisors LLC is based out at San Juan, PR

Below you can find more details about Alpha Centric Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $121 Million
Healthcare: $73.7 Million
Real Estate: $14.6 Million
ETFs: $13.7 Million
Financial Services: $8.78 Million
Industrials: $3.69 Million
Technology: $3.37 Million
Consumer Cyclical: $1.6 Million
Energy: $614,000
Other: $1.16 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 218
  • Current Value $121 Million
  • Prior Value $144 Million
  • Filing
  • Period Q2 2024
  • Filing Date July 25, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 35 stocks
  • Additional Purchases 55 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 86 stocks
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.